ArticleBiomedical journal2025

Chronic low-dose REV-ERBs agonist SR9009 mitigates constant light-induced weight gain and insulin resistance via adipogenesis modulation.

Ming-Yu Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.